Fairvalue-Calculator Fairvalue-Calculator
EN DE

Arecor Therapeutics plc (AREC) Fair Value & Analysis

Healthcare · GB · Market cap 26.4M GBX

Pricep0.6250
Fair Valuep0.3900
Upside-37.6%
Quality95/100
Evidence: Medium Range p0.2900 – p0.4800

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Arecor Therapeutics plc (AREC) currently trades at p0.6250, while our model-based Fair Value estimate is p0.3900 — implying the stock looks roughly 37.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Arecor Therapeutics plc, a clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom. The company's lead therapeutic product is the AT278, a disruptor insulin which is designed to transform Automated Insulin Delivery (AID) systems to improve patient care for people living with diabetes. It also develops a novel oral delivery platform using a GLP-1 receptor agonist. Arecor Therapeutics plc was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Arecor Therapeutics plc (AREC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p0.3900 versus a price of p0.6250 — about −38% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AREC?
Our 21-model fair value for Arecor Therapeutics plc is p0.3900 (as of Jun 24, 2026), built from audited fundamentals. The current price is p0.6250.
What is the quality score of AREC?
Arecor Therapeutics plc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.